Señales en vivo de 003060.KS | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 02:30):

Aprogen pharmaceuticals,Inc. manufactures and sells pharmaceutical products primarily in South Korea. It offers approximately 200 types of medicines, including ethical and over the counter drugs...

Stats
Volumen de hoy	91 708.00
Volumen promedio	871 083
Capitalización de mercado	103.17B
EPS	KRW0 ( 2024-03-15 )
Próxima fecha de ganancias	( KRW0 ) 2024-05-10
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW1.861 (0.12%)

Volumen Correlación

Largo: 0.04 (neutral)

Corto: 0.68 (moderate)

Signal:(51.871) Neutral

Aprogen Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Aprogen Correlación - Moneda/Commodity

0.32
( neutral )

0.38
( neutral )

-0.20
( neutral )

-0.05
( neutral )

0.42
( neutral )

-0.49
( neutral )

Aprogen Finanzas

Annual	2023
Ingresos:	KRW87.36B
Beneficio Bruto:	KRW-12.05B (-13.79 %)
EPS:	KRW-187.48

FY	2023
Ingresos:	KRW87.36B
Beneficio Bruto:	KRW-12.05B (-13.79 %)
EPS:	KRW-187.48

FY	2022
Ingresos:	KRW65.19B
Beneficio Bruto:	KRW27.29B (41.86 %)
EPS:	KRW13.81

FY	2021
Ingresos:	KRW56.48B
Beneficio Bruto:	KRW25.44B (45.05 %)
EPS:	KRW25.52

Financial Reports:

No articles found.

Aprogen

Aprogen pharmaceuticals,Inc. manufactures and sells pharmaceutical products primarily in South Korea. It offers approximately 200 types of medicines, including ethical and over the counter drugs. The company offers its drugs for transfusion, digestive system, osteoarthritis, skeletal muscle relaxants, NSAIDs, osteoporosis, circulatory system, endocrine, respiratory system, urinary system, depilatory, antihistamines and antiallergics, obesity, brain function, neurologics, and male pattern hair loss. It also provides anti-biotic, anti-fungal, anti-viral, anti-ulcerant, anti-epliepsy products; external agents; anti-cancer drugs; amino-acid nutrient transfusion agents; and cosmetics. The company was formerly known as Schnell Biopharmaceuticals, Inc. and changed its name to Aprogen pharmaceuticals,Inc. in April 2017. Aprogen pharmaceuticals,Inc. was founded in 1960 and is headquartered in Seongnam, South Korea.